Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of the Culture Based Tailored Therapy for Helicobacter Pylori Eradication Comparing With the Traditional 2nd Line Rescue Therapy in Korean

NCT02349685 is registered in ClinicalTrials.gov with Seoul National University Bundang Hospital as lead sponsor.

NCT NCT02349685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02349685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of the Culture Based Tailored Therapy for Helicobacter Pylori Eradication Comparing With the Traditional 2nd Line Rescue Therapy in Korean
Lead sponsor
Seoul National University Bundang Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2010
Completion date
June 30, 2014
Enrollment
219 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter infection